Your browser doesn't support javascript.
loading
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.
Kar, Siddhartha P; Adler, Emily; Tyrer, Jonathan; Hazelett, Dennis; Anton-Culver, Hoda; Bandera, Elisa V; Beckmann, Matthias W; Berchuck, Andrew; Bogdanova, Natalia; Brinton, Louise; Butzow, Ralf; Campbell, Ian; Carty, Karen; Chang-Claude, Jenny; Cook, Linda S; Cramer, Daniel W; Cunningham, Julie M; Dansonka-Mieszkowska, Agnieszka; Doherty, Jennifer Anne; Dörk, Thilo; Dürst, Matthias; Eccles, Diana; Fasching, Peter A; Flanagan, James; Gentry-Maharaj, Aleksandra; Glasspool, Rosalind; Goode, Ellen L; Goodman, Marc T; Gronwald, Jacek; Heitz, Florian; Hildebrandt, Michelle A T; Høgdall, Estrid; Høgdall, Claus K; Huntsman, David G; Jensen, Allan; Karlan, Beth Y; Kelemen, Linda E; Kiemeney, Lambertus A; Kjaer, Susanne K; Kupryjanczyk, Jolanta; Lambrechts, Diether; Levine, Douglas A; Li, Qiyuan; Lissowska, Jolanta; Lu, Karen H; Lubinski, Jan; Massuger, Leon F A G; McGuire, Valerie; McNeish, Iain; Menon, Usha.
Afiliación
  • Kar SP; Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK.
  • Adler E; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.
  • Tyrer J; Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK.
  • Hazelett D; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK.
  • Anton-Culver H; Bioinformatics and Computational Biology Research Center, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Bandera EV; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Beckmann MW; Department of Epidemiology, Director of Genetic Epidemiology Research Institute, UCI Center for Cancer Genetics Research & Prevention, School of Medicine, University of California Irvine, Irvine, CA 92697, USA.
  • Berchuck A; Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA.
  • Bogdanova N; University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Universitaetsstrasse 21-23, Erlangen 91054, Germany.
  • Brinton L; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA.
  • Butzow R; Radiation Oncology Research Unit, Hannover Medical School, Hannover 30625, Germany.
  • Campbell I; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
  • Carty K; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki 00100, Finland.
  • Chang-Claude J; Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, VIC 3002, Australia.
  • Cook LS; Department of Pathology, University of Melbourne, Parkville, VIC 3010, Australia.
  • Cramer DW; The Beatson West of Scotland Cancer Centre, Glasgow G12 0YN, UK.
  • Cunningham JM; German Cancer Research Center, Division of Cancer Epidemiology, Heidelberg 69120, Germany.
  • Dansonka-Mieszkowska A; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
  • Doherty JA; Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, NM 87131, USA.
  • Dörk T; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA 02215, USA.
  • Dürst M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
  • Eccles D; Department of Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw 02-781, Poland.
  • Fasching PA; Department of Epidemiology, The Geisel School of Medicine-at Dartmouth, Hanover, NH 03756, USA.
  • Flanagan J; Gynaecology Research Unit, Hannover Medical School, Hannover 30625, Germany.
  • Gentry-Maharaj A; Department of Gynecology, Jena-University Hospital-Friedrich Schiller University, Jena 07737, Germany.
  • Glasspool R; Faculty of Medicine, University of Southampton, Southampton SO16 5YA, UK.
  • Goode EL; University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg, Universitaetsstrasse 21-23, Erlangen 91054, Germany.
  • Goodman MT; Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
  • Gronwald J; Department of Surgery & Cancer, Imperial College London, London SW7 2AZ, UK.
  • Heitz F; Department of Women's Cancer, Institute for Women's Health, University College London, London W1T 7DN, UK.
  • Hildebrandt MA; The Beatson West of Scotland Cancer Centre, Glasgow G12 0YN, UK.
  • Høgdall E; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MI 55905, USA.
  • Høgdall CK; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Huntsman DG; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Jensen A; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 70-001, Poland.
  • Karlan BY; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen 45136, Germany.
  • Kelemen LE; Department of Gynecology and Gynecologic Oncology, Dr Horst Schmidt Kliniken Wiesbaden, Wiesbaden 65199, Germany.
  • Kiemeney LA; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Kjaer SK; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen 2100, Denmark.
  • Kupryjanczyk J; Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen 1165, Denmark.
  • Lambrechts D; The Juliane Marie Centre, Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.
  • Levine DA; British Columbia's Ovarian Cancer Research (OVCARE) Program, Vancouver General Hospital, BC Cancer Agency and University of British Columbia, Vancouver, BC V5Z 1L3, Canada.
  • Li Q; Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC V5Z 1L3, Canada.
  • Lissowska J; Department of Molecular Oncology, BC Cancer Agency Research Centre, Vancouver, BC V5Z 1L3, Canada.
  • Lu KH; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen 2100, Denmark.
  • Lubinski J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Massuger LF; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29435, USA.
  • McGuire V; Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen 6500 HB, The Netherlands.
  • McNeish I; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen 2100, Denmark.
  • Menon U; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark.
Br J Cancer ; 116(4): 524-535, 2017 Feb 14.
Article en En | MEDLINE | ID: mdl-28103614
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Transformación Celular Neoplásica / Amplificación de Genes / Cistadenocarcinoma Seroso / Neoplasias Glandulares y Epiteliales / Predisposición Genética a la Enfermedad / Sitios Genéticos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Ováricas / Transformación Celular Neoplásica / Amplificación de Genes / Cistadenocarcinoma Seroso / Neoplasias Glandulares y Epiteliales / Predisposición Genética a la Enfermedad / Sitios Genéticos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido